| 产品详情 |
| Edit |   |
| Product Name | TRAIL, Recombinant, Human, aa114-281 |
| Description | Purity ~95% (SDS-PAGE). TNF-related apoptosis-inducing ligand (TRAIL) belongs to the tumor necrosis factor (TNF) cytokine family and induces rapid apoptosis in a wide variety of tumor cell lines upon binding to the death-signalling receptors on the cell membrane. TRAIL binds to one of four receptors that have been identified in humans, including TRAIL-R1/DR4, TRAIL- R2/KILLER/DR5, TRAIL-R3/DcR1/TRID, and TRAIL-R4/DcR2/TRUNDD. Both DR4 and DR5 are pro-apoptotic receptors, which contain a cytoplasmic death domain and mediate apoptosis on binding to TRAIL. By contrast, TRID and TRUNDD do not contain a cytoplasmic death domain and block the function of TRAIL by competing with DR4 and DR5 for binding of TRAIL. Source: Recombinant protein corresponding to aa114-281 from human TRAIL, expressed in E. coli. Molecular Weight: ~19.6kD (169aa) Endotoxin: <1EU/1ug (determined by LAL method) Biological Activity: Measured in a cell cytotoxicity assay using Jurkat human T lymphocyte. The ED50 for this effect is ≤1ng/ml. AA |
| Size | 10ug, 50ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | TRAIL, Recombinant, Human, aa114-281 (TNF-Related Apoptosis Inducing Ligand, TNFSF10, Apo-2L, APO2L, CD253, TL2) |
| Gene, Accession, CAS # | Accession: NP_003801 |
| Catalog # | 377993 |
| Price | |
| Order / More Info | TRAIL, Recombinant, Human, aa114-281 from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|